Generally, most state Medicaid programs cover GLP-1s for the treatment of Type 2 diabetes, cardiovascular disease, and obstructive sleep apnea, says Jennifer Brown, MD, board-certified obesity medicine doctor at MyObesityTeam
Notably, GSH is more likely to bind to the L2 and L4 regions near CuA
Based on early-phase clinical trial data including a Phase 2 study published in the New England Journal of Medicine (2023) retatrutide has demonstrated significant effects on appetite suppression and glucose regulation
Apart from being used for treating T2DM, GLP-1 has a close relationship with AD and BP
The FDA approves specific mass-produced drug products after extensive clinical trials, but it does not approve individual batches of custom-made compounded medications